Stock DNA
Pharmaceuticals & Biotechnology
CNY 7,543 Million (Mid Cap)
25.00
NA
0.16%
0.22
10.49%
3.63
Revenue and Profits:
Net Sales:
325 Million
(Quarterly Results - Mar 2026)
Net Profit:
27 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.19%
0%
9.19%
6 Months
-1.6%
0%
-1.6%
1 Year
0.95%
0%
0.95%
2 Years
8.91%
0%
8.91%
3 Years
18.21%
0%
18.21%
4 Years
47.49%
0%
47.49%
5 Years
0%
0%
0.0%
Hunan Warrant Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.78%
EBIT Growth (5y)
-2.62%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.69
Tax Ratio
11.03%
Dividend Payout Ratio
10.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.36%
ROE (avg)
12.38%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
2.79
EV to EBIT
42.15
EV to EBITDA
32.62
EV to Capital Employed
2.79
EV to Sales
3.76
PEG Ratio
NA
Dividend Yield
0.21%
ROCE (Latest)
6.61%
ROE (Latest)
11.30%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
324.50
336.20
-3.48%
Operating Profit (PBDIT) excl Other Income
30.30
57.70
-47.49%
Interest
1.20
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
26.90
37.20
-27.69%
Operating Profit Margin (Excl OI)
93.50%
112.90%
-1.94%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -3.48% vs -9.04% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -27.69% vs -29.28% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,495.50
1,387.20
7.81%
Operating Profit (PBDIT) excl Other Income
215.60
204.50
5.43%
Interest
0.90
0.30
200.00%
Exceptional Items
72.70
0.00
Consolidate Net Profit
228.10
138.80
64.34%
Operating Profit Margin (Excl OI)
92.90%
95.50%
-0.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 7.81% vs -1.86% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 64.34% vs -28.08% in Dec 2024
About Hunan Warrant Pharmaceutical Co., Ltd. 
Hunan Warrant Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






